Loading...

Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ

The DCISionRT test estimates the risk of an ipsilateral breast event (IBE) in patients with ductal carcinoma in situ (DCIS) as well as the benefit of adjuvant radiation therapy (RT). We determined the cost-effectiveness of DCISionRT using a Markov model simulating 10-year outcomes for 60-year-old wo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JNCI Cancer Spectr
Main Authors: Raldow, Ann C, Sher, David, Chen, Aileen B, Punglia, Rinaa S
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083239/
https://ncbi.nlm.nih.gov/pubmed/32211582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa004
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!